Imperial Innovations Group PLC, the technology commercialisation and investment company, and London-focused The Capital Fund have together invested Gbp850,000 to co-lead an investment round of Gbp2.44 million for IXICO Ltd., an image analysis solutions provider for the pharmaceutical industry.
One downside of taking venture capital from a public company is that the deal can wind up in an 8-K filing. At that point, startups have two basic choices: Ignore the filing and hope nobody notices, or grudgingly emerge from stealth mode. But there's a big caveat: If your company was funded by Google, forget […]
The Audax Group is raising up to $1 billion for its third private equity fund, according to a regulatory filing. The Boston-based firm closed its second private equity fund in 2004 with $700 million, and also raised a $700 million mezzanine fund last year. www.audaxgroup.com
Vibrynt Inc., a Mountain View, Calif.-based medical device startup, has raised around $16 million in Series A funding, according to a regulatory filing. New Enterprise Associates led the deal, and was joined by Delphi Ventures.
Translink Capital is raising up to $75 million for its debut venture capital fund, according to a regulatory filing. The Palo Alto, Calif.-based firm already has secured around $21 million from limited partners like UMC Capital and Nikko Antfactory. www.translinkcapital.com
3-V Biosciences Inc., a Menlo Park, Calif.-based developer of antiviral drugs to fight influenza virus, respiratory syncitial virus and rhinovirus, has raised $7.61 million in Series A funding, according to a regulatory filing. Backers include Kleiner Perkins Caufield & Byers, The Column Group and Wilson Sonsini.
WASHINGTON (AP) – SLM Corp., the student lender commonly known as Sallie Mae, on Tuesday said Thomas J. Fitzpatrick, vice chairman and chief executive, is resigning to pursue other interests and being replaced by the company's chief financial officer. Over the next few weeks, Fitzpatrick, 58, will serve the company in an advisory role to […]
QuatRx Pharmaceuticals Co., an Ann Arbor, Mich.-based drug company focused on endocrine, metabolic and cardiovascular disorders, has raised $44 million in Series E funding. The capital will be used to complete ongoing Phase 3 and Phase 2 clinical studies of QuatRx's two endocrine programs, and Phase 1 clinical studies with its lipid-lowering compound. Venrock led […]
MuleSource, a San Francisco
Intechra Holding Corp., a Carrolton, Texas-based IT asset disposition company, has raised $30 million in fourth-round funding. Participants include Richland Ventures, Oxford Bioscience Partners, First Avenue Partners, Chrysalis Ventures, Sewanee Partners and SJF Ventures. www.intechra.com